The FDA has authorized an expanded access program that will allow for the use of a recombinant bacillus Calmette-Guerin product.

FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.

ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...

Shares of ImmunityBio Inc. surged 16.4% on Wednesday, marking their best session in over a month, and extended gains in after ...

ImmunityBio (IBRX) announced the U.S. Food and Drug Administration FDA has authorized an expanded access program EAP that will bring a vital ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA ...

The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...

The Business Research Company TICE BCG Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The TICE BCG market size is expected to see XX (FCAGR) in the next few years. It w ...

The TICE BCG market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX ...

In this special episode of Football 301, Nate Tice and Matt Harmon join you live to break down the Philadelphia Eagles' dominant Super Bowl victory over the Kansas City Chiefs.

Leon Robert Tice Jr., 84, died Jan. 30 at the Iowa Medical Classification Center, the Iowa Department of Corrections announced Wednesday. Tice had been serving a life sentence for his 1963 ...

Leon Tice Jr. was pronounced dead at 11:14 a.m. last Thursday at the Iowa Medical and Classification Center, according to a news release. The 84-year-old was serving life in prison. He was ...